Semaglutide Cost 2026: The Complete Guide to Every Pricing Option
Brand-name semaglutide costs up to $1,349 per month. Compounded alternatives start at $99. This guide consolidates every pricing tier, provider comparison, insurance scenario, and cost-reduction strategy so you can find your actual number — not a generic range.
Written by Trimi Medical Team. Medically reviewed by Dr. Amanda Foster, MD. Authority hub consolidating 10+ cost articles for trytrimi.com. All pricing reflects April 2026 rates; verify current figures directly with each provider.
Jump to: Brand pricing • Compounded providers • Insurance • Medicare Part D • HSA/FSA • Savings programs • Definitive answer • FAQs
2026 Semaglutide Price Summary
- Wegovy (brand, 2.4 mg): ~$1,349/month retail; $0–$25 with savings card (insured)
- Ozempic (brand, diabetes): ~$935/month retail; widely covered for T2D
- Trimi (compounded): $99/month — all-inclusive
- Mochi Health (compounded): $99/month medication + $79/month membership
- Hims/Hers (compounded): $199/month
- Ro (compounded): $149–$299/month depending on dose
- Noom Med (compounded): $149/month
More on Semaglutide Cost & Affordability
Cheapest Semaglutide Options 2026
Every semaglutide source ranked by monthly price with quality ratings.
Cheapest GLP-1 Providers Ranked
Side-by-side comparison of every major telehealth GLP-1 provider.
Compounded Semaglutide: Cost vs. Safety Guide
What to know before choosing compounded over brand-name.
Wegovy Cost 2026: What Patients Actually Pay
Brand-name Wegovy pricing broken down by dose, insurance, and savings cards.
Brand-Name Semaglutide Pricing in 2026
Two FDA-approved brand-name semaglutide products are available in the United States: Wegovy (semaglutide 2.4 mg) indicated for chronic weight management, and Ozempic (semaglutide 0.5 mg, 1 mg, 2 mg) indicated for type 2 diabetes. Despite containing the same active molecule, they carry different list prices, insurance coverage pathways, and manufacturer savings programs.
Wegovy (Semaglutide 2.4 mg)
- Retail list price~$1,349/mo
- With savings card (insured)$0–$25/mo
- With insurance (est. co-pay)$50–$200/mo
- Annual retail cost~$16,188
- Annual insured cost (typical)$600–$2,400
Starter dose (0.25 mg) and maintenance dose (2.4 mg) ship at the same list price per pen package. Dose-titration pens differ; patients pay for the package, not the dose level.
Ozempic (Semaglutide 0.5–2 mg)
- Retail list price~$935/mo
- With savings card (insured)$0–$25/mo
- With insurance (T2D)$25–$100/mo
- Annual retail cost~$11,220
- Annual insured cost (T2D)$300–$1,200
Ozempic is FDA-approved for type 2 diabetes only. Off-label prescribing for weight loss is at provider discretion; insurance typically requires a T2D diagnosis for coverage.
List price vs. net price: Novo Nordisk's published list prices include rebates paid to pharmacy benefit managers. The net price insurers and PBMs actually pay is lower. However, uninsured cash-pay patients typically pay close to the list price unless they use a GoodRx coupon or manufacturer program. Always verify current pricing at the pharmacy before filling.
Semaglutide Cost by Dose Level
For compounded semaglutide, dose and monthly cost are directly linked because pharmacies price by the milligrams dispensed. This is one of the key structural differences between compounded and brand-name pricing — and it matters for your budget as you titrate up.
| Dose Level | Compounded (Trimi est.) | Brand (Wegovy retail) |
|---|---|---|
| 0.25 mg/week (starter) | ~$99/mo | ~$1,349/mo |
| 0.5 mg/week | ~$99/mo | ~$1,349/mo |
| 1.0 mg/week | ~$109/mo | ~$1,349/mo |
| 1.7 mg/week | ~$119/mo | ~$1,349/mo |
| 2.4 mg/week (maintenance) | ~$149/mo | ~$1,349/mo |
Compounded dose pricing varies by provider and pharmacy. Trimi prices shown are estimates; verify current rates at trytrimi.com. Brand prices reflect approximate 2026 AWP; actual pharmacy prices may differ.
Compounded Semaglutide by Provider: 2026 Comparison
The telehealth compounded semaglutide market has grown significantly since 2022. Multiple providers now offer compounded semaglutide at dramatically lower prices than brand-name options. Pricing structures differ — some bundle the provider visit, some charge membership fees separately, and some have additional fees for higher doses. Here is how the major players compare as of April 2026.
Trimi
Lowest PriceAll-inclusive compounded semaglutide: provider visit, medication, shipping, and ongoing clinical check-ins covered in one flat monthly price. Partners with PCAB-accredited and FDA-registered 503B compounding pharmacies.
- No membership fee
- Accredited pharmacy sourcing
- No insurance required
$99
/month
all-inclusive
Mochi Health
Telehealth platform with a separate membership fee for coaching and provider access. Medication pricing starts at $99/month but requires an additional $79/month membership fee, bringing the effective monthly total to $178 for most patients.
- $79/mo membership fee required
- Coaching and dietitian included
$178
/month total
($99 med + $79 membership)
Noom Med
Combines behavioral coaching with compounded semaglutide prescribing. Medication starts at $149/month for lower doses; the Noom app coaching subscription is bundled. Total cost increases at higher doses.
- App-based behavioral support included
- Price increases at higher doses
$149
/month
starting price
Ro (Body Program)
Compounded semaglutide with an integrated telehealth platform. Pricing ranges from $149 for starter doses up to $299 at maintenance dose. Includes metabolic tracking and ongoing provider check-ins.
- Higher price at maintenance dose
- Strong clinical monitoring
$149–$299
/month
dose-dependent
Hims / Hers
Hims (for men) and Hers (for women) offer compounded semaglutide through their telehealth platforms. Pricing is typically $199/month and includes the provider visit and medication.
- Simple single-price model
- Pricier than Trimi for identical compound
$199
/month
Calibrate
Calibrate focuses on insurance-covered GLP-1 medications (brand-name) paired with a metabolic health coaching program. The program fee runs ~$199/month; medication cost is separate and depends on your insurance. Not a compounded option — Calibrate works to get brand-name coverage approved.
- Helps navigate insurance coverage
- Program fee is on top of medication cost
~$199
/month program
+ medication separately
Prices are estimates based on publicly available information as of April 2026. All providers change their pricing periodically. Verify current pricing directly with each provider before enrolling. See our full GLP-1 provider cost comparison for additional detail on each platform.
Insurance Coverage for Semaglutide: What to Expect in 2026
Insurance coverage for semaglutide is fragmented and depends on your diagnosis (diabetes vs. weight management), your insurer, your employer plan design, and whether the medication is Ozempic or Wegovy. Understanding these distinctions determines whether you pay $25 or $1,349 per month for the same active ingredient.
Generally Covered
- Ozempic for type 2 diabetes (most commercial plans)
- Wegovy for obesity with BMI 30+ (many large employer plans)
- Wegovy for BMI 27+ with one comorbidity (select plans)
- Wegovy for cardiovascular risk reduction under Medicare Part D (see below)
- Ozempic for cardiovascular risk reduction (FDA-approved indication)
Frequently Not Covered
- Wegovy for weight loss on many individual market plans
- Ozempic off-label for weight management (most plans)
- Weight-loss medications on most Medicaid plans
- Medicare Part D for obesity alone (excluding cardiovascular indication)
- Compounded semaglutide (almost never covered by insurance)
If your plan denies Wegovy coverage, prior authorization appeals can succeed — especially if your provider documents a BMI over 30 or a BMI over 27 with comorbidities such as hypertension, dyslipidemia, or sleep apnea. Our insurance denial appeal guide walks through the step-by-step process. For patients without coverage, the cash-pay semaglutide guide compares uninsured options.
Medicare Part D Semaglutide Coverage: 2026 Update
Key 2024–2026 Medicare Changes
- January 2024: CMS guidance allows Medicare Part D plans to cover Wegovy for patients with established cardiovascular disease (prior heart attack, stroke, or peripheral arterial disease). This is the SELECT trial indication.
- 2025 (in effect): Inflation Reduction Act's $2,000 annual out-of-pocket cap on Part D medications is fully active — a major cost relief for Medicare patients with coverage.
- Coverage for obesity only: Still generally excluded under Part D. Congress would need to pass the TREAT Act or similar legislation to broadly expand coverage.
Medicare beneficiaries with established cardiovascular disease who are prescribed Wegovy for that indication should check their specific Part D plan formulary — coverage and tier placement vary significantly by plan. Those without the cardiovascular indication remain without Part D coverage in most cases. For Medicare patients paying out-of-pocket, compounded semaglutide at $99/month may be the most accessible option, though Medicare does not cover compounded medications either. Patients in this situation pay cash regardless of route — compounded is far cheaper.
Medicare beneficiaries who qualify for Extra Help (Low Income Subsidy) have additional protections. For Ozempic prescribed for type 2 diabetes under Part D, coverage is broader and co-pays under Extra Help can be minimal. See our full insurance coverage guide for Medicare-specific navigation.
HSA and FSA Strategies for Semaglutide Costs
Health Savings Accounts (HSA) and Flexible Spending Accounts (FSA) are among the most underutilized cost-reduction tools for patients paying out-of-pocket for semaglutide. Because HSA and FSA contributions are pre-tax, every dollar spent through these accounts is effectively discounted by your marginal tax rate.
22%
Average tax bracket for middle-income earners — effective discount on HSA spending
$264
Annual savings on $1,200/yr semaglutide cost at 22% tax bracket via HSA
$4,300
2026 HSA contribution limit (individual) — more than covers annual compounded semaglutide cost
To qualify as an HSA/FSA-eligible expense, semaglutide must be prescribed by a licensed provider for a qualifying medical purpose — which includes obesity, type 2 diabetes, prediabetes management, and cardiovascular risk reduction. Both brand-name and compounded semaglutide qualify under these conditions. The telehealth visit fee through Trimi also qualifies as a medical expense.
How to use your HSA/FSA for compounded semaglutide
- Receive your prescription and receipt from Trimi (or your chosen provider).
- Submit the itemized receipt through your HSA/FSA administrator's portal.
- Most administrators accept telehealth prescriptions; keep your Letter of Medical Necessity on file.
- Some HSA debit cards can be used directly at checkout — verify with your card issuer.
FSA accounts have a use-it-or-lose-it rule for most employers — plan your annual semaglutide spending during open enrollment so you can allocate the appropriate amount. HSA funds roll over indefinitely and can grow tax-free, making them the preferred vehicle for patients with high-deductible health plans.
Manufacturer Savings Programs and Patient Assistance
Novo Nordisk maintains savings programs for both Wegovy and Ozempic. These programs can dramatically reduce costs for eligible patients, but they come with important eligibility restrictions — most critically, they exclude Medicare and Medicaid beneficiaries.
Wegovy Savings Card (WeGoTogether)
- Eligibility: Commercially insured patients only (no Medicare/Medicaid)
- Benefit: Co-pay as low as $0/month for the first month, then $25/month for eligible patients
- Duration: Up to 24 months; terms subject to change
- Enrollment: wegovy.com/savings
Terms and eligibility change frequently. Verify current offer directly with Novo Nordisk before making treatment decisions based on savings card availability.
Ozempic Savings Card
- Eligibility: Commercially insured T2D patients (no Medicare/Medicaid)
- Benefit: Co-pay as low as $25/month for eligible patients
- Duration: Ongoing; terms subject to change
- Enrollment: ozempic.com/savings
NovoCare Patient Assistance Program
- Eligibility: Uninsured or underinsured patients who meet income criteria
- Benefit: Free medication for qualifying patients
- Income threshold: Typically up to 400% of federal poverty level (verify at novocare.com)
- Application: Requires provider participation and documentation
NovoCare is valuable for uninsured patients who cannot afford brand-name pricing and do not have access to or prefer to avoid compounded options. The application process takes several weeks — plan ahead.
For patients who do not qualify for manufacturer programs — particularly Medicare beneficiaries and the uninsured without income eligibility — compounded semaglutide at $99/month through Trimi is typically the most cost-accessible legitimate option. See our semaglutide cost savings strategies guide for a comprehensive breakdown of every available discount mechanism.
Annual and Multi-Year Cost Projections
Semaglutide is typically used for 12–24+ months for sustained weight management. Understanding the total cost of a full treatment course — not just the monthly price — is essential for financial planning. The annual gap between brand-name and compounded options is stark.
| Scenario | Monthly | Year 1 | Year 2 |
|---|---|---|---|
| Trimi (compounded, starter dose) | $99 | $1,188 | $2,376 |
| Trimi (compounded, maintenance dose) | $149 | $1,788 | $3,576 |
| Hims/Hers (compounded) | $199 | $2,388 | $4,776 |
| Ro (compounded, maintenance) | $299 | $3,588 | $7,176 |
| Wegovy with savings card (insured) | $25 | $300 | $600 |
| Wegovy retail (uninsured, no card) | $1,349 | $16,188 | $32,376 |
These projections assume no dose changes mid-year. Real costs may vary. Read our full annual GLP-1 cost analysis for dose-transition modeling.
Two-year savings comparison: A patient choosing Trimi compounded semaglutide at $149/month (maintenance dose) versus brand-name Wegovy retail at $1,349/month saves approximately $28,800 over two years. Even compared to Hims at $199/month, Trimi saves $1,200 per year. The math compounds significantly over a full treatment course.
The Definitive Answer: Cheapest Way to Get Semaglutide in 2026
After comparing every option, here is the clearest answer organized by patient situation:
If you have commercial insurance that covers Wegovy:
Enroll in the Wegovy Savings Card. Your monthly cost drops to $0–$25 for up to 24 months. This is the lowest-cost path if you qualify. Action: Get a Wegovy prescription and enroll at wegovy.com/savings. See how to maximize insurance coverage.
If you are uninsured or your insurance does not cover weight-loss medications:
Compounded semaglutide through Trimi at $99/month is the cheapest all-in option. No insurance required, no membership fee, accredited pharmacy, board-certified provider included. See our cheapest semaglutide 2026 guide for full qualification details.
If you are on Medicare without cardiovascular disease:
Part D does not cover Wegovy for obesity alone. Compounded semaglutide at $99/month cash-pay is typically the most affordable access route. The Novo Nordisk savings card does not apply to Medicare patients. See affordable weight loss programs for Medicare patients.
If you have type 2 diabetes and need glycemic management:
Ozempic with commercial insurance and the Ozempic Savings Card ($25/month) is likely your cheapest route to brand-name semaglutide. Compounded semaglutide at equivalent doses is still a valid and cheaper cash-pay option if insurance does not cover or you prefer a simpler process.
If you want to add pre-tax savings on top of any option:
Pair any of the above with HSA or FSA contributions to reduce effective cost by your marginal tax rate.
More on Cost & Affordability
Insurance Coverage for GLP-1 Medications
How to check your plan, appeal denials, and maximize benefits.
Annual Cost of GLP-1 Therapy
12-month and 24-month cost projections for every major GLP-1.
Appealing Insurance Denials for GLP-1 Medications
Step-by-step guide to winning prior-authorization appeals.
Compounded GLP-1 Price Comparison
How compounded semaglutide and tirzepatide prices compare across providers.
More Cost & Pricing Resources
Frequently Asked Questions
How much does semaglutide cost per month in 2026?
Semaglutide costs vary dramatically by source. Brand-name Wegovy (weight-loss dose 2.4 mg) has a retail price near $1,349 per month without insurance. Ozempic (diabetes indication) runs approximately $935 per month at retail. Compounded semaglutide through telehealth programs like Trimi starts at $99 per month — up to 93% less. Your actual out-of-pocket cost depends on insurance coverage, manufacturer savings programs, and whether you use brand-name or compounded formulations.
Is compounded semaglutide the same as Wegovy or Ozempic?
Compounded semaglutide contains the same active pharmaceutical ingredient — semaglutide — as Wegovy and Ozempic. The mechanism of action, expected weight loss outcomes, and side effect profile are clinically identical. Differences lie in the manufacturing source (FDA-registered compounding pharmacy versus Novo Nordisk), the delivery device, and the price. Quality compounded semaglutide from PCAB-accredited or 503B facilities undergoes the same third-party potency and sterility testing as the brand-name versions.
What is the cheapest way to get semaglutide in 2026?
The cheapest legitimate path to semaglutide in 2026 is compounded semaglutide through a telehealth program with in-house prescribing and an accredited pharmacy. Trimi offers compounded semaglutide starting at $99 per month — an all-inclusive price covering the provider visit, medication, and shipping. Other budget-friendly compounded options include Mochi Health ($99 medication + $79 membership fee) and Ro ($149–$199). These represent 85–93% savings versus brand-name retail pricing.
Does insurance cover semaglutide for weight loss in 2026?
Coverage varies significantly. Ozempic (semaglutide 0.5–2 mg) is broadly covered for type 2 diabetes management by most commercial plans. Wegovy (semaglutide 2.4 mg for weight loss) coverage depends heavily on your employer plan — approximately 40–50% of large employer plans now cover anti-obesity medications. Medicare Part D historically excluded weight-loss drugs but CMS issued guidance in 2024 allowing Part D plans to cover Wegovy when prescribed for cardiovascular risk reduction (patients who have established cardiovascular disease). Medicaid coverage varies by state.
What are the Medicare Part D semaglutide changes for 2026?
Medicare Part D plans may now cover Wegovy for enrolled patients with established cardiovascular disease (prior heart attack, stroke, or peripheral arterial disease) following CMS guidance effective January 2024. Coverage for weight loss without a cardiovascular indication is still generally excluded under Part D. The Inflation Reduction Act's $2,000 annual out-of-pocket cap on Part D drugs took full effect in 2025, meaningfully reducing costs for patients who do have coverage. Check your specific Part D plan formulary, as coverage and tier placement vary by plan.
Can I use HSA or FSA funds to pay for semaglutide?
Yes — semaglutide prescribed for a qualifying medical condition (type 2 diabetes, obesity, or cardiovascular risk reduction) is generally an eligible HSA and FSA expense. Both brand-name and compounded semaglutide qualify when prescribed by a licensed provider. Using pre-tax HSA or FSA dollars effectively reduces your cost by your marginal tax rate — typically 22–32% for most patients. If you are paying $99–$199 per month out-of-pocket, routing that through an HSA saves $22–$64 per month in real terms.
What savings programs reduce Wegovy and Ozempic costs?
Novo Nordisk offers the Wegovy Savings Card, which can reduce co-pays to as low as $0 per month for eligible commercially-insured patients. The Ozempic Savings Card similarly reduces cost for insured diabetes patients. Both programs exclude Medicare and Medicaid beneficiaries. Novo Nordisk also operates a Patient Assistance Program (NovoCare) for uninsured patients who meet income eligibility requirements. Terms and eligibility change frequently — patients should verify current offers directly at wegovy.com or ozempic.com.
Start Semaglutide for $99/Month — No Insurance Required
Trimi offers compounded semaglutide at $99/month — all-inclusive. Board-certified provider review, accredited compounding pharmacy, and free shipping in one transparent price.
See How Trimi WorksRequires a completed health assessment and provider approval. Not available in all states.
Sources & References
- Wilding JPH et al. STEP 1 trial: once-weekly semaglutide 2.4 mg for obesity. NEJM 2021;384:989-1002.
- Lincoff AM et al. SELECT trial: semaglutide and cardiovascular outcomes without diabetes. NEJM 2023;389:2221-2232.
- FDA guidance on drug compounding regulations.
- CMS: Medicare Part D guidance on anti-obesity medications (2024).
- CMS: Inflation Reduction Act — $2,000 Part D out-of-pocket cap (2025).
- NABP compounding pharmacy accreditation standards.
- IRS Publication 502: Medical and Dental Expenses (HSA/FSA eligible expenses).
- Wegovy (semaglutide 2.4 mg) FDA prescribing information.
- NIDDK: Prescription medications to treat overweight and obesity.
- KFF: Coverage of obesity treatment — analysis of Medicaid and employer plans.
Medical Disclaimer: This content is for informational purposes only and does not constitute medical advice. All pricing information reflects estimated figures as of April 2026 and is subject to change — verify current prices directly with each provider before making decisions. Always consult a qualified healthcare provider before starting or changing any medication. Trimi provides compounded GLP-1 medications and has a commercial interest in patients choosing Trimi — we have endeavored to present accurate comparative information, but readers should independently verify competing provider pricing.